Stock Quote
Noven Pharmaceuticals Inc (NOVN.O) (Nasdaq)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View NOVN on other exchanges
$16.47
27 Aug 2009
+0.00%
$16.47
--
928,118
$16.47
$16.47
$16.84
$7.54
0.81
0
NOVN.O
More News
| Press Releases
| Key Developments
Profile
Noven Pharmaceuticals, Inc. (Noven) is a specialty pharmaceutical company engaged in the research, development, manufacturing, licensing, marketing and sale of prescription pharmaceutical products. Its business is focused in three segments: Noven Transdermals, its transdermal drug delivery segment;... Full Description
Company Address
Noven Pharmaceuticals Inc
11960 S.W. 144th Street
Miami FL 33186
P: +1305.2535099
F: +1305.2511887
11960 S.W. 144th Street
Miami FL 33186
P: +1305.2535099
F: +1305.2511887
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.69 | +0.38 |
| Novartis AG | CHF55.15 | +1.20 |
| Eli Lilly & Co. | $36.80 | +0.21 |
| NOVN.O | Industry | |
|---|---|---|
| P/E(TTM) | 15.65 | 3.57 |
| P/S(TTM) | 3.55 | 0.57 |
| ROI(TTM) | 10.74 | 1.86 |
| ROE(TTM) | 16.38 | 2.51 |
| Consensus Recommendation | |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $26.77M |
| Net Income | $7.27M |
| EPS | $0.29 |
